PD1 inhibitor-induced apoptotic enteropathy in the duodenum

Gastrointest Endosc. 2019 Nov;90(5):854-855. doi: 10.1016/j.gie.2019.06.023. Epub 2019 Jun 28.

Authors

Andreas Blesl¹, Florian Rainer¹, Marion J Pollheimer²

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
² Institute of Pathology, Medical University of Graz, Graz, Austria.

PMID: 31260657
DOI: 10.1016/j.gie.2019.06.023

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Apoptosis
Duodenitis / chemically induced*
Duodenitis / pathology*
Endoscopy, Gastrointestinal
Female
Humans
Middle Aged
Programmed Cell Death 1 Receptor / antagonists & inhibitors

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
PDCD1 protein, human
Programmed Cell Death 1 Receptor
pembrolizumab